FDA Orders Tobacco Company to Stop Sales of New Cigarettes

Share this content:
FDA Orders Tobacco Company to Stop Sales of New Cigarettes
FDA Orders Tobacco Company to Stop Sales of New Cigarettes

WEDNESDAY, Sept. 16, 2015 (HealthDay News) -- The U.S. Food and Drug Administration has ordered the R.J. Reynolds Tobacco Co. to stop selling four new cigarette brands because submissions for these products did not meet requirements set forth in the Federal Food, Drug, and Cosmetic Act, according to an announcement issued Sept. 15 by the agency.

The FDA determined that the cigarettes are substantially different from existing Reynolds tobacco products on the market and need a full agency review before they can be marketed. The cigarettes are Camel Crush Bold, Pall Mall Deep Set Recessed Filter, Pall Mall Deep Set Recessed Filter Menthol and Vantage Tech 13.

These new cigarettes contain higher levels of some ingredients and ingredients that were not in the comparison products, the agency said Tuesday. Camel Crush Bold, for example, contains a menthol capsule in its filter that the agency believes would make it more attractive to younger smokers.

"These products had been provisionally marketed while our scientific review has taken place," Mitch Zeller, J.D., director of the FDA's Center for Tobacco Products, explained during a morning news conference. But going forward, these products can no longer "be sold, distributed, imported or marketed in interstate commerce," Zeller said. Selling or distributing these brands could result in FDA enforcement action, including seizure, the agency said. Retail stores, however, have 30 days to dispose of any inventory on hand.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »